Day One Biopharmaceuticals, Inc.
Board Member
2024-01-17–present
Board Member
Day One Biopharmaceuticals, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Habib J. Dable is recorded as Board Member at Day One Biopharmaceuticals, Inc.. Day One Biopharmaceuticals, Inc. reported in an 8-K filed January 17, 2024 that Habib J. Dable was appointed Class III director, effective January 17, 2024.
“On January 16, 2024, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Day One Biopharmaceuticals, Inc. (the "Company"), the Board increased the size of the Board to ten directors and appointed each of Habib J. Dable and William Grossman as a Class III and Class II director, respectively, effective as of January 17, 2024 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Day One Biopharmaceuticals, Inc.
Board Member
SEC 8-K
2024-01-17–present
Recorded roles and call appearances connecting this person to public companies.
Day One Biopharmaceuticals, Inc.
Board Member
2024-01-17–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.